Amylyx Pharmaceuticals, Inc. AMLX Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s other income, net (note 6)?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported other income, net (note 6) of -$75K in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s other income, net (note 6) changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s other income, net (note 6) increased by 77.6% year-over-year, from -$335K to -$75K.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.